Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Child and Adolescent Mental Health
|
April 11, 2015
The use and trends of information and communication technology (ICT) during middle childhood
Anet E Louw, Melanie Winter
Journal of Clinical Medicine
|
August 14, 2025
Analysis of Calcaneal Fracture-Related Complications-A Retrospective Chart Review
Géraldine Désirée Sturz-Jantsch, Melanie Winter, Stefan Hajdu, et al.
Cancers
|
January 28, 2026
Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions
Melanie Winter, Jan Jeroch, Maximilian Wetz, et al.
Frontiers in Medicine
|
August 8, 2025
FGFR4 p.Gly388Arg polymorphism in PBMCs of LAM patients: findings of a pilot study
Sinem Koc-Gunel, Amy L Ryan, Melanie Winter, et al.
Biomedicines
|
January 28, 2026
Malignant Melanoma: Landscape of Molecular Markers
Melanie Winter, Silvana Ebner, Viola Baum, et al.
Nature Cell Biology
|
June 10, 2008
Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR
Melanie Winter, Dirk Sombroek, Ilka Dauth, et al.
Cancers
|
March 13, 2025
Evaluation of an <i>IDH1/2</i> Mutation FastTrack Assay for Patients with Cholangiocarcinoma
Melanie Winter, Silvana Ebner, Nina Scheuber, et al.
Plos One
|
July 6, 2026
Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy
Christoph Steup, Antonia Mondorf, Peter Wild, et al.
Aging
|
January 12, 2016
Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles
Sylvia Weilner, Verena Keider, Melanie Winter, et al.
Future Oncology (London, England)
|
November 21, 2025
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer
Friederike C Althoff, Fabian Acker, Sebastian Koschade, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Child and Adolescent Mental Health
|
April 11, 2015
The use and trends of information and communication technology (ICT) during middle childhood
Anet E Louw, Melanie Winter
Journal of Clinical Medicine
|
August 14, 2025
Analysis of Calcaneal Fracture-Related Complications-A Retrospective Chart Review
Géraldine Désirée Sturz-Jantsch, Melanie Winter, Stefan Hajdu, et al.
Cancers
|
January 28, 2026
Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions
Melanie Winter, Jan Jeroch, Maximilian Wetz, et al.
Frontiers in Medicine
|
August 8, 2025
FGFR4 p.Gly388Arg polymorphism in PBMCs of LAM patients: findings of a pilot study
Sinem Koc-Gunel, Amy L Ryan, Melanie Winter, et al.
Biomedicines
|
January 28, 2026
Malignant Melanoma: Landscape of Molecular Markers
Melanie Winter, Silvana Ebner, Viola Baum, et al.
Nature Cell Biology
|
June 10, 2008
Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR
Melanie Winter, Dirk Sombroek, Ilka Dauth, et al.
Cancers
|
March 13, 2025
Evaluation of an <i>IDH1/2</i> Mutation FastTrack Assay for Patients with Cholangiocarcinoma
Melanie Winter, Silvana Ebner, Nina Scheuber, et al.
Plos One
|
July 6, 2026
Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy
Christoph Steup, Antonia Mondorf, Peter Wild, et al.
Aging
|
January 12, 2016
Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles
Sylvia Weilner, Verena Keider, Melanie Winter, et al.
Future Oncology (London, England)
|
November 21, 2025
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer
Friederike C Althoff, Fabian Acker, Sebastian Koschade, et al.
Page
of 2